122 research outputs found
Estimation of Immune Cell Densities in Immune Cell Conglomerates: An Approach for High-Throughput Quantification
Determining the correct number of positive immune cells in immunohistological sections of colorectal cancer and other tumor entities is emerging as an important clinical predictor and therapy selector for an individual patient. This task is usually obstructed by cell conglomerates of various sizes. We here show that at least in colorectal cancer the inclusion of immune cell conglomerates is indispensable for estimating reliable patient cell counts. Integrating virtual microscopy and image processing principally allows the high-throughput evaluation of complete tissue slides.For such large-scale systems we demonstrate a robust quantitative image processing algorithm for the reproducible quantification of cell conglomerates on CD3 positive T cells in colorectal cancer. While isolated cells (28 to 80 microm(2)) are counted directly, the number of cells contained in a conglomerate is estimated by dividing the area of the conglomerate in thin tissues sections (< or =6 microm) by the median area covered by an isolated T cell which we determined as 58 microm(2). We applied our algorithm to large numbers of CD3 positive T cell conglomerates and compared the results to cell counts obtained manually by two independent observers. While especially for high cell counts, the manual counting showed a deviation of up to 400 cells/mm(2) (41% variation), algorithm-determined T cell numbers generally lay in between the manually observed cell numbers but with perfect reproducibility.In summary, we recommend our approach as an objective and robust strategy for quantifying immune cell densities in immunohistological sections which can be directly implemented into automated full slide image processing systems
CytoASP: a Cytoscape app for qualitative consistency reasoning, prediction and repair in biological networks
Background: Qualitative reasoning frameworks, such as the Sign Consistency Model (SCM), enable modelling regulatory networks to check whether observed behaviour can be explained or if unobserved behaviour can be predicted. The BioASP software collection offers ideal tools for such analyses. Additionally, the Cytoscape platform can offer extensive functionality and visualisation capabilities. However, specialist programming knowledge is required to use BioASP and no methods exist to integrate both of these software platforms effectively. Results: We report the implementation of CytoASP, an app that allows the use of BioASP for influence graph consistency checking, prediction and repair operations through Cytoscape. While offering inherent benefits over traditional approaches using BioASP, it provides additional advantages such as customised visualisation of predictions and repairs, as well as the ability to analyse multiple networks in parallel, exploiting multi-core architecture. We demonstrate its usage in a case study of a yeast genetic network, and highlight its capabilities in reasoning over regulatory networks. Conclusion: We have presented a user-friendly Cytoscape app for the analysis of regulatory networks using BioASP. It allows easy integration of qualitative modelling, combining the functionality of BioASP with the visualisation and processing capability in Cytoscape, and thereby greatly simplifying qualitative network modelling, promoting its use in relevant projects
Nuclear staining and relative distance for quantifying epidermal differentiation in biomarker expression profiling
<p>Abstract</p> <p>Background</p> <p>The epidermal physiology results from a complex regulated homeostasis of keratinocyte proliferation, differentiation and death and is tightly regulated by a specific protein expression during cellular maturation. Cellular <it>in silico </it>models are considered a promising and inevitable tool for the understanding of this complex system. Hence, we need to incorporate the information of the differentiation dependent protein expression in cell based systems biological models of tissue homeostasis. Such methods require measuring tissue differentiation quantitatively while correlating it with biomarker expression intensities.</p> <p>Results</p> <p>Differentiation of a keratinocyte is characterized by its continuously changing morphology concomitant with its movement from the basal layer to the surface, leading to a decreased average nuclei density throughout the tissue. Based thereon, we designed and evaluated three different mathematical measures (nuclei based, distance based, and joint approach) for quantifying differentiation in epidermal keratinocytes. We integrated them with an immunofluorescent staining and image analysis method for tissue sections, automatically quantifying epidermal differentiation and measuring the corresponding expression of biomarkers. When studying five well-known differentiation related biomarkers in an epidermal neck sample only the resulting biomarker profiles incorporating the relative distance information of cells to the tissue borders (distance based and joint approach) provided a high-resolution view on the whole process of keratinocyte differentiation. By contrast, the inverse nuclei density approach led to an increased resolution at early but heavily decreased resolution at late differentiation. This effect results from the heavy non-linear decay of DAPI intensity per area, probably caused by cytoplasmic growth and chromatin decondensation. In the joint approach this effect could be compensated again by incorporating distance information.</p> <p>Conclusion</p> <p>We suppose that key mechanisms regulating tissue homeostasis probably depend more on distance information rather than on nuclei reorganization. Concluding, the distance approach appears well suited for comprehensively observing keratinocyte differentiation.</p
Molecular Alterations and Association with Clinical Parameters
Lynch syndrome is caused by germline mutations of DNA mismatch repair (MMR)
genes, most frequently MLH1 and MSH2. Recently, MMR-deficient crypt foci (MMR-
DCF) have been identified as a novel lesion which occurs at high frequency in
the intestinal mucosa from Lynch syndrome mutation carriers, but very rarely
progress to cancer. To shed light on molecular alterations and clinical
associations of MMR-DCF, we systematically searched the intestinal mucosa from
Lynch syndrome patients for MMR-DCF by immunohistochemistry. The identified
lesions were characterised for alterations in microsatellite-bearing genes
with proven or suspected role in malignant transformation. We demonstrate that
the prevalence of MMR-DCF (mean 0.84 MMR-DCF per 1 cm2 mucosa in the
colorectum of Lynch syndrome patients) was significantly associated with
patientsâ age, but not with patientsâ gender. No MMR-DCF were detectable in
the mucosa of patients with sporadic MSI-H colorectal cancer (n = 12).
Microsatellite instability of at least one tested marker was detected in 89%
of the MMR-DCF examined, indicating an immediate onset of microsatellite
instability after MMR gene inactivation. Coding microsatellite mutations were
most frequent in the genes HT001 (ASTE1) with 33%, followed by AIM2 (17%) and
BAX (10%). Though MMR deficiency alone appears to be insufficient for
malignant transformation, it leads to measurable microsatellite instability
even in single MMR-deficient crypts. Our data indicate for the first time that
the frequency of MMR-DCF increases with patientsâ age. Similar patterns of
coding microsatellite instability in MMR-DCF and MMR-deficient cancers suggest
that certain combinations of coding microsatellite mutations, including
mutations of the HT001, AIM2 and BAX gene, may contribute to the progression
of MMR-deficient lesions into MMR-deficient cancers
Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma
Background: An inverse correlation between expression of the aldehyde dehydrogenase 1 subfamily A2 (ALDH1A2) and gene promoter methylation has been identified as a common feature of oropharyngeal squamous cell carcinoma (OPSCC). Moreover, low ALDH1A2 expression was associated with an unfavorable prognosis of OPSCC patients, however the causal link between reduced ALDH1A2 function and treatment failure has not been addressed so far. Methods: Serial sections from tissue microarrays of patients with primary OPSCC (n = 101) were stained by immunohistochemistry for key regulators of retinoic acid (RA) signaling, including ALDH1A2. Survival with respect to these regulators was investigated by univariate Kaplan-Meier analysis and multivariate Cox regression proportional hazard models. The impact of ALDH1A2-RAR signaling on tumor-relevant processes was addressed in established tumor cell lines and in an orthotopic mouse xenograft model. Results: Immunohistochemical analysis showed an improved prognosis of ALDH1A2high OPSCC only in the presence of CRABP2, an intracellular RA transporter. Moreover, an ALDH1A2highCRABP2high staining pattern served as an independent predictor for progression-free (HR: 0.395, p = 0.007) and overall survival (HR: 0.303, p = 0.002), suggesting a critical impact of RA metabolism and signaling on clinical outcome. Functionally, ALDH1A2 expression and activity in tumor cell lines were related to RA levels. While administration of retinoids inhibited clonogenic growth and proliferation, the pharmacological inhibition of ALDH1A2-RAR signaling resulted in loss of cell-cell adhesion and a mesenchymal-like phenotype. Xenograft tumors derived from FaDu cells with stable silencing of ALDH1A2 and primary tumors from OPSCC patients with low ALDH1A2 expression exhibited a mesenchymal-like phenotype characterized by vimentin expression. Conclusions: This study has unraveled a critical role of ALDH1A2-RAR signaling in the pathogenesis of head and neck cancer and our data implicate that patients with ALDH1A2low tumors might benefit from adjuvant treatment with retinoids
Tumor cell load and heterogeneity estimation from diffusion-weighted MRI calibrated with histological data: an example from lung cancer
ProducciĂłn CientĂficaDiffusion-weighted magnetic resonance imaging (DWI) is a key non-invasive imaging technique for cancer diagnosis and tumor treatment assessment, reflecting Brownian movement of water molecules in tissues. Since densely packed cells restrict molecule mobility, tumor tissues produce usually higher signal (a.k.a. less attenuated signal) on isotropic maps compared with normal tissues. However, no general quantitative relation between DWI data and the cell density has been established. In order to link low-resolution clinical cross-sectional data with high-resolution histological information, we developed an image processing and analysis chain, which was used to study the correlation between the diffusion coefficient (D value) estimated from DWI and tumor cellularity from serial histological slides of a resected non-small cell lung cancer tumor. Color deconvolution followed by cell nuclei segmentation was performed on digitized histological images to determine local and cell-type specific 2d (two-dimensional) densities. From these, the 3d cell density was inferred by a model-based sampling technique, which is necessary for the calculation of local and global 3d tumor cell count. Next, DWI sequence information was overlaid with high-resolution CT data and the resected histology using prominent anatomical hallmarks for co-registration of histology tissue blocks and non-invasive imaging modalities' data. The integration of cell numbers information and DWI data derived from different tumor areas revealed a clear negative correlation between cell density and D value. Importantly, spatial tumor cell density can be calculated based on DWI data. In summary, our results demonstrate that tumor cell count and heterogeneity can be predicted from DWI data, which may open new opportunities for personalized diagnosis and therapy optimization
Organotypic Co-Cultures as a Novel 3D Model for Head and Neck Squamous Cell Carcinoma
Background: Head and neck squamous cell carcinomas (HNSCC) are phenotypically and
molecularly heterogeneous and frequently develop therapy resistance. Reliable patient-derived 3D
tumor models are urgently needed to further study the complex pathogenesis of these tumors and
to overcome treatment failure. Methods: We developed a three-dimensional organotypic co-culture
(3D-OTC) model for HNSCC that maintains the architecture and cell composition of the individual
tumor. A dermal equivalent (DE), composed of healthy human-derived fibroblasts and viscose fibers,
served as a scaffold for the patient sample. DEs were co-cultivated with 13 vital HNSCC explants
(non-human papillomavirus (HPV) driven, n = 7; HPV-driven, n = 6). Fractionated irradiation was
applied to 5 samples (non-HPV-driven, n = 2; HPV-driven n = 3). To evaluate expression of ki-67,
cleaved caspase-3, pan-cytokeratin, p16INK4a, CD45, âsmooth muscle actin and vimentin over time,
immunohistochemistry and immunofluorescence staining were performed Patient checkup data
were collected for up to 32 months after first diagnosis. Results: All non-HPV-driven 3D-OTCs
encompassed proliferative cancer cells during cultivation for up to 21 days. Proliferation indices of
primaries and 3D-OTCs were comparable and consistent over time. Overall, tumor explants displayed heterogeneous growth patterns (i.e., invasive, expansive, silent). Cancer-associated fibroblasts and
leukocytes could be detected for up to 21 days. HPV DNA was detectable in both primary and
3D-OTCs (day 14) of HPV-driven tumors. However, p16INK4a expression levels were varying.
Morphological alterations and radioresistant tumor cells were detected in 3D-OTC after fractionated
irradiation in HPV-driven and non-driven samples. Conclusions: Our 3D-OTC model for HNSCC
supports cancer cell survival and proliferation in their original microenvironment. The model enables
investigation of invasive cancer growth and might, in the future, serve as a platform to perform
sensitivity testing upon treatment to predict therapy response
Antiproliferative efficacies but minor drug transporter inducing effects of paclitaxel, cisplatin, or 5-fluorouracil in a murine xenograft model for head and neck squamous cell carcinoma
Drug-induced multidrug resistance (MDR) has been linked to overexpression of drug transporting proteins in head and neck squamous cell carcinoma (HNSCC) in vitro. The aim of this work was to reassess these findings in a murine xenograft model. NOD-SCID mice xenotransplanted with 106 HNO97 cells were treated for four consecutive weeks with weekly paclitaxel, biweekly cisplatin (both intraperitoneal), or 5-fluorouracil (5-FU, administered by osmotic pump). Tumor volume and body weight were weekly documented. Expression of drug transporters and Ki-67 marker were examined using quantitative real-time polymerase chain reaction and/or immunohistochemistry. Both paclitaxel and cisplatin significantly reduced tumor volumes after 2â3 weeks. 5-FU-treated animals had significantly lower body weights after 2 or 4 weeks of chemotherapy. None of the drugs affected expression of drug transporters at the mRNA level. However, P-glycoprotein (Pgp) protein expression was increased by paclitaxel (P < 0.01). Ki-67 expression did not change during treatment irrespective of the drug applied. Paclitaxel and cisplatin are effectively tumor volume reducing drugs in a murine xenograft model of HNSCC. Paclitaxel enhanced Pgp expression at the protein level, but not at the mRNA level suggesting transcriptional induction to be of minor relevance. In contrast, posttranscriptional mechanisms or Darwinian selection of intrinsically drug transporter overexpressing MDR cells might lead to iatrogenic chemotherapy resistance in HNSCC.Fil: Theile, Dirk. UniversitĂ€t Heidelberg; AlemaniaFil: Gal, Zoltan. UniversitĂ€t Heidelberg; AlemaniaFil: Warta, Rolf. UniversitĂ€t Heidelberg; AlemaniaFil: Rigalli, Juan Pablo. UniversitĂ€t Heidelberg; Alemania. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas; ArgentinaFil: Lahrmann, Bernd. UniversitĂ€t Heidelberg; AlemaniaFil: Grabe, Niels. UniversitĂ€t Heidelberg; AlemaniaFil: Herold Mende, Christel. UniversitĂ€t Heidelberg; AlemaniaFil: Dyckhoff, Gerhard. UniversitĂ€t Heidelberg; AlemaniaFil: Weiss, Johanna. UniversitĂ€t Heidelberg; Alemani
- âŠ